Literature DB >> 16498831

Antemortem diagnosis and treatment of toxoplasmosis in two cats on cyclosporin therapy.

V R Barrs1, P Martin, J A Beatty.   

Abstract

Clinical toxoplasmosis was diagnosed antemortem in two cats being treated with therapeutic doses of cyclosporin. The diagnosis was made by detecting tachyzoites on cytological examination of bronchoalveolar lavage fluid from one case and pleural effusion from the other. Despite early diagnosis and aggressive treatment in both cases, only one cat survived. Reactivation of latent Toxoplasma gondii infection secondary to cyclosporin-induced immunosuppression was considered likely in both cases. The presence of respiratory signs in cats treated with cyclosporin should alert clinicians to the possibility of clinical toxoplasmosis. Consideration should be given to determining the serostatus of cats to T gondii prior to use of drugs which are potent inhibitors of cell mediated immunity, such as cyclosporin. Two cases of feline toxoplasmosis are presented.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16498831     DOI: 10.1111/j.1751-0813.2006.tb13119.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  12 in total

1.  Parasitemia due to Sarcocystis neurona-like infection in a clinically ill domestic cat.

Authors:  Nina C Zitzer; Antoinette E Marsh; Mary Jo Burkhard; M Judith Radin; Maxey L Wellman; Maria Jugan; Valerie Parker
Journal:  Vet Clin Pathol       Date:  2017-09-11       Impact factor: 1.180

2.  Systemic fungal infection in a dog: a unique case in Ireland.

Authors:  Sabela Atencia; Stratos Papakonstantinou; Bernadette Leggett; Hester McAllister; Carmel T Mooney
Journal:  Ir Vet J       Date:  2014-08-06       Impact factor: 2.146

3.  Presumed immune-mediated haemolytic anaemia associated with pregnancy in a cat.

Authors:  Matthew A Kopke; Sarah Pemberton; Craig G Ruaux
Journal:  JFMS Open Rep       Date:  2019-04-04

4.  A blinded, randomized, placebo-controlled trial of the safety of oclacitinib in cats.

Authors:  Natália Lôres Lopes; Diefrey Ribeiro Campos; Marília Alves Machado; Mariana Silva Revoredo Alves; Manuela Silva Gomes de Souza; Cristiano Chaves Pessoa da Veiga; Alexandre Merlo; Fábio Barbour Scott; Julio Israel Fernandes
Journal:  BMC Vet Res       Date:  2019-05-08       Impact factor: 2.741

Review 5.  Clinical Toxoplasmosis in Dogs and Cats: An Update.

Authors:  Rafael Calero-Bernal; Solange M Gennari
Journal:  Front Vet Sci       Date:  2019-02-26

Review 6.  Lower respiratory tract infections in cats: reaching beyond empirical therapy.

Authors:  Susan F Foster; Patricia Martin
Journal:  J Feline Med Surg       Date:  2011-05       Impact factor: 2.015

7.  ACVIM consensus statement on pancreatitis in cats.

Authors:  Marnin A Forman; Joerg M Steiner; P Jane Armstrong; Melinda S Camus; Lorrie Gaschen; Steve L Hill; Caroline S Mansfield; Katja Steiger
Journal:  J Vet Intern Med       Date:  2021-02-15       Impact factor: 3.333

8.  Reversibility of clinical and computed tomographic lesions mimicking pulmonary fibrosis in a young cat.

Authors:  Alba Stavri; Isabelle Masseau; Carol R Reinero
Journal:  BMC Vet Res       Date:  2021-12-09       Impact factor: 2.741

9.  Dose tapering for ciclosporin in cats with nonflea-induced hypersensitivity dermatitis.

Authors:  Jean Steffan; Elizabeth Roberts; Andrea Cannon; Pascal Prélaud; Peter Forsythe; Jacques Fontaine; Stephen King; Wolfgang Seewald
Journal:  Vet Dermatol       Date:  2013-03-27       Impact factor: 1.589

Review 10.  The cat with neurological manifestations of systemic disease. Key conditions impacting on the CNS.

Authors:  Marc Kent
Journal:  J Feline Med Surg       Date:  2009-05       Impact factor: 2.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.